发展基于OMV的细菌疫苗

CD Bioparticles’ new service suite provides a streamlined pathway from initial concept to preclinical evaluation, including pathogen strain acquisition and identification, OMV extraction & purification, engineered OMV design (eOMV), and quality control & functional testing. Other services, like OMV lyophilization and formulation development and GLP-compliant animal studies support are also available at CD Bioparticles.